'Poised for outperformance', JPM starts Aedifica at 'overweight'
** JPM initiates coverage of Aedifica AOO.BR with an "overweight" rating, says the Belgian healthcare real estate company operates in a resilient sub-sector with stable and predictable cash flows
** It says healthcare real estate operators' occupancy rates are well above 80% in Europe and rising year on year, despite price increases
** "Ability to pass rent increases through to tenants outperforms other sectors, ensuring a reliable flow of income," it says, adding that healthcare tenants are more reliable in paying rent vs other sectors like retail
** The broker also points to M&A and investments becoming more feasible for the sector as debt costs start falling
** "An improvement in M&A visibility may imply further equity raises in medium term, which for right reasons should be taken as an opportunity to re-engage" - JPM
** The broker sets PT of 70 euros, which is 15.5% above Thursday's closing price of 60.60 euros
** Out of 17 analysts that cover Aedifica, 10 rate the stock "strong buy" or "buy", six rate it "hold" one rates it "sell"
Reporting by Olivier Sorgho
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
